This policy brief summarizes the results of the EURION cluster, a collaboration between eight research projects dedicated to providing new testing and screening methods to identify endocrine disrupting chemicals (EDCs), funded under the European Union’s Horizon 2020 Research and Innovation program.
The research in EURION focused on four endocrine-related health domains: thyroid hormone system disruption (ATHENA, ERGO, SCREENED), metabolic disorders (EDCMET, GOLIATH, OBERON), developmental neurotoxicity (ENDpoiNTs) and female fertility (FREIA).